Immunoglobulins, complement and foreign antigens in human tumor cells

Area of Science:

• Immunology
• Oncology
• Pathology

Background:

• Neoplasia involves abnormal cell growth, and its relationship with the immune system is complex.
• Immunologic reactants may play a role in the development and progression of tumors.
• Previous studies suggest altered immune profiles in cancerous tissues.

Purpose of the Study:

• To investigate the presence and frequency of immunologic reactants in malignant and benign neoplasia.
• To compare immunologic activity in tumors versus control tissues.
• To identify specific antigens associated with neoplastic tissues.

Main Methods:

• Utilized fluorescein-labeled antibodies (FA) targeting human immunoglobulins, complement, fetal proteins, and other antigens.
• Examined malignant tumors, benign tumors, and normal control tissues.
• Quantified positive staining for five or more specific antibodies as an indicator of significant immunologic activity.

Main Results:

• Significant immunologic activity (≥5 antigens) was detected in 70% of malignant tumors (42/59) and 40% of benign tumors (21/23).
• Normal tissues and remaining neoplasia showed positive staining with fewer than five specific antibodies.
• Immunoglobulin M (IgM), Immunoglobulin A (IgA), B1C, fetal proteins, and herpes simplex virus (HSV) were the most frequently detected antigens.

Conclusions:

• Neoplasia exhibits a higher frequency of immunologic activity compared to normal tissue.
• The presence of multiple immunologic reactants suggests an active immune response within tumors.
• Specific antigens like IgM, IgA, and fetal proteins are frequently associated with neoplastic processes.